Literature DB >> 34055205

Pyrrolo-pyridazine Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators.

Benjamin E Blass1.   

Abstract

Entities:  

Year:  2021        PMID: 34055205      PMCID: PMC8155267          DOI: 10.1021/acsmedchemlett.1c00118

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.

Authors:  Christian C Felder; Paul J Goldsmith; Kimberley Jackson; Helen E Sanger; David A Evans; Adrian J Mogg; Lisa M Broad
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

Review 2.  Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia.

Authors:  Samantha E Yohn; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2017-09-09       Impact factor: 5.250

Review 3.  Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders.

Authors:  Daniel Erskine; John-Paul Taylor; Geor Bakker; Alastair J H Brown; Tim Tasker; Pradeep J Nathan
Journal:  Drug Discov Today       Date:  2019-09-06       Impact factor: 7.851

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.